BamSEC and AlphaSense Join Forces
Learn More

Sensei Biotherapeutics Inc. – Material Contracts

NASDAQ: SNSE    
Share price (6/3/26): $15.85    
Market cap (6/3/26): $21.3 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 10-Q 3 pages Sensei Biotherapeutics, Inc. Non-Employee Director Compensation Policy as Amended and Restated Effective April 10, 2026
12/34/56
EX-10.1
from 10-Q 14 pages Sensei Biotherapeutics, Inc. Severance Plan and Summary Plan Description Approved by the Board of Directors: April 10, 2026 1
12/34/56
EX-10.25
from 10-K 4 pages Modifications of Base Salary and Target Percentage Retention Bonus
12/34/56
EX-10.24
from 10-K 4 pages Modifications of Base Salary and Target Percentage Retention Bonus
12/34/56
EX-10.23
from 10-K 13 pages Certain Information Has Been Excluded From This Agreement (Indicated by “[***]”) Because Such Information Is Both (A) Not Material and (B) the Type That the Registrant Customarily and Actually Treats as Private or Confidential. January 29, 2026 (The “Effective Date”) Millennium Pharmaceuticals, Inc. 40 Landsdowne Street Cambridge, Ma 02139 United States Takeda Pharmaceutical Company Limited 40 Landsdowne Street Cambridge, Ma 02139 United States Re: Tak-228 and Tak-117 Combination Product
12/34/56
EX-10.22
from 10-K 8 pages May 15, 2023 Millennium Pharmaceuticals, Inc. 40 Landsdowne Street Cambridge, Ma 02139 United States
12/34/56
EX-10.21
from 10-K 76 pages Amended and Restated Tak 228 Asset Purchase Agreement Between Millennium Pharmaceuticals, Inc. and Calithera Biosciences, Inc. Dated as of May 15, 2023
12/34/56
EX-10.20
from 10-K 38 pages License Agreement
12/34/56
EX-10.19
from 10-K 69 pages Exclusive License Agreement Between the Regents of the University of California and Intellikine, Inc. for [***]
12/34/56
EX-10.15
from 10-K 3 pages February 17, 2026 Josiah Craver Re: Amendment to Retention Agreement Dear Josiah
12/34/56
EX-10.14
from 10-K 3 pages February 17, 2026 Christopher W. Gerry Re: Amendment to Retention Agreement Dear Chris
12/34/56
EX-10.10
from 10-K 15 pages Amended and Restated Employment Agreement
12/34/56
EX-10.6
from 10-K 51 pages 2019 Stock Incentive Plan of Faeth Therapeutics, Inc
12/34/56
EX-10.4
from 8-K 11 pages Sensei Biotherapeutics, Inc. Inducement Grant Outside of 2021 Equity Incentive Plan Stock Option Grant Notice
12/34/56
EX-10.3
from 8-K 2 pages February 17, 2026 Anand Parikh Re: Employment Terms Dear Anand Parikh
12/34/56
EX-10.2
from 8-K 26 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 35 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 10-Q 10 pages Independent Contractor Agreement
12/34/56
EX-10.1
from 10-Q 15 pages Employment Agreement
12/34/56
EX-10.4
from 10-Q 4 pages Amendment No. 1 to Services Agreement
12/34/56